SEARCH

SEARCH BY CITATION

References

  • 1
    Pharmacy The Report of a Committee of Inquiry Appointed by the Nuffield Foundation London: Nuffield Foundation 1986
  • 2
    The Royal Pharmaceutical Society of Great Britain and Department of Health Joint Working Party Pharmaceutical Care: the Future for Community Pharmacy London: The Royal Pharmaceutical Society of Great Britain 1992
  • 3
    The Royal Pharmaceutical Society of Great Britain The New Horizon: Pharmacy in a New Age London: The Royal Pharmaceutical Society of Great Britain 1996
  • 4
    Department of Health Choice and Opportunity : Primary Care: the Future London: HMSO October 1996
  • 5
    Department of Health The NHS—a Service with Ambitions London: HMSO November 1996
  • 6
    Department of Health Primary Care—Delivering the Future London: HMSO December 1996
  • 7
    Helper CD & Strand LMOpportunities and responsibilities in pharmaceutical care.Am J Hosp Pharm1990; 47: 533 543
  • 8
    Hawksworth GM & Chrystyn HPrescriber contacted interventions in a community pharmacy.Pharm J1994; 253 (Suppl.): R9
  • 9
    Shulman JL, Shulman S, Haines APThe prevention of adverse drug reactions.J R Coll Gen Pract1981; 31: 429 434
  • 10
    Neville RG, Robertson F, Livingstone S et al. A classification of prescribing errors.J Coll Gen Pract1989; 39: 110 112
  • 11
    Donaldson SM, Radley AS, Kendall HEApplication of a formal prescription monitoring service to community pharmacy.Int J Pharm Pract1995; 3: 110 114
  • 12
    Green RSurvey of prescribing anomalies in community pharmacies.Interventions Outcomes Pharm J1995; 254: 873 875
  • 13
    Rupp MT, De Young M, Schondelmeyer SWPrescribing problems and pharmacist interventions in community pharmacy.Med Care1992; 30: 924 940
  • 14
    Hannoui A, Krass I, Benrimoj SIReview of patient medication records to determine potential clinical interventions in community pharmacy.Int J Pharm Pract1996; 4: 162 167
  • 15
    Caleo S, Benrimoj SI, Collins D et al. Clinical evaluation of community pharmacists’ interventions.Int J Pharm Pract1996; 4: 221 227
  • 16
    Poston J, Kennedy R, Waruszynski BHigh volume/low cost pharmacy service. A vision for the future. Canadian Pharmaceutical Association 1994.
  • 17
    Hulls V & Emmerton LPrescription interventions in New Zealand community practice.J Soc Admin Pharm1996; 13: 198 204
  • 18
    Bellingan M & Wiseman ICPharmacist interventions in an elderly care facility.Int J Pharm Pract1996; 4: 25 29
  • 19
    Smith L, McGowan L, Moss-Barclay C et al. An investigation of hospital generated pharmaceutical care when patients are discharged home from hospital.Br J Clin Pharmacol1997; 44: 163 165
  • 20
    Hurwitz N & Wade OLIntensive hospital monitoring of adverse drug reactions to drugs.Br Med J1969; 1: 531 536
  • 21
    Caranoss GJ, Stewart RB, Cluff LEDrug induced illness leading to hospitalisation.JAMA1974; 228: 713 717
  • 22
    Miller RRHospital admissions due to adverse drug reaction. A report from the Boston Collaborative Drug Surveillance Program.Arch Int Med1974; 134: 219 223
  • 23
    Nolan L & O’Malley KPrescribing for the elderly: Part 1. Sensitivity of the elderly to adverse drug reactions.J Am Geriat Soc1988; 36: 142 149
  • 24
    Prince BS, Goetz CM, Rihn Tl, et al.Drug related emergency department visits and hospital admissions.Am J Hosp Pharm1992; 49: 1696 1700
  • 25
    Zermansky AWho controls repeats?Br J Gen Pract1996; 46: 643 647
  • 26
    Harris CMThe scale of repeat prescribing.Br J Gen Pract1996; 46: 649 653
  • 27
    Mulroy RIatrogenic disease in general practice, its incidence and effects.Br Med J1973; 2: 407 410